385 related articles for article (PubMed ID: 28747530)
21. Induction of HIV Neutralizing Antibody Lineages in Mice with Diverse Precursor Repertoires.
Tian M; Cheng C; Chen X; Duan H; Cheng HL; Dao M; Sheng Z; Kimble M; Wang L; Lin S; Schmidt SD; Du Z; Joyce MG; Chen Y; DeKosky BJ; Chen Y; Normandin E; Cantor E; Chen RE; Doria-Rose NA; Zhang Y; Shi W; Kong WP; Choe M; Henry AR; Laboune F; Georgiev IS; Huang PY; Jain S; McGuire AT; Georgeson E; Menis S; Douek DC; Schief WR; Stamatatos L; Kwong PD; Shapiro L; Haynes BF; Mascola JR; Alt FW
Cell; 2016 Sep; 166(6):1471-1484.e18. PubMed ID: 27610571
[TBL] [Abstract][Full Text] [Related]
22. The effects of somatic hypermutation on neutralization and binding in the PGT121 family of broadly neutralizing HIV antibodies.
Sok D; Laserson U; Laserson J; Liu Y; Vigneault F; Julien JP; Briney B; Ramos A; Saye KF; Le K; Mahan A; Wang S; Kardar M; Yaari G; Walker LM; Simen BB; St John EP; Chan-Hui PY; Swiderek K; Kleinstein SH; Alter G; Seaman MS; Chakraborty AK; Koller D; Wilson IA; Church GM; Burton DR; Poignard P
PLoS Pathog; 2013; 9(11):e1003754. PubMed ID: 24278016
[TBL] [Abstract][Full Text] [Related]
23. Highly mutated antibodies capable of neutralizing N276 glycan-deficient HIV after a single immunization with an Env trimer.
Lee JH; Nakao C; Appel M; Le A; Landais E; Kalyuzhniy O; Hu X; Liguori A; Mullen TM; Groschel B; Abbott RK; Sok D; Schief WR; Crotty S
Cell Rep; 2022 Mar; 38(10):110485. PubMed ID: 35263576
[TBL] [Abstract][Full Text] [Related]
24. HIV Broadly Neutralizing Antibodies: VRC01 and Beyond.
Wu X
Adv Exp Med Biol; 2018; 1075():53-72. PubMed ID: 30030789
[TBL] [Abstract][Full Text] [Related]
25. Functional Relevance of Improbable Antibody Mutations for HIV Broadly Neutralizing Antibody Development.
Wiehe K; Bradley T; Meyerhoff RR; Hart C; Williams WB; Easterhoff D; Faison WJ; Kepler TB; Saunders KO; Alam SM; Bonsignori M; Haynes BF
Cell Host Microbe; 2018 Jun; 23(6):759-765.e6. PubMed ID: 29861171
[TBL] [Abstract][Full Text] [Related]
26. Germlining of the HIV-1 broadly neutralizing antibody domain m36.
Chen W; Li W; Ying T; Wang Y; Feng Y; Dimitrov DS
Antiviral Res; 2015 Apr; 116():62-6. PubMed ID: 25676867
[TBL] [Abstract][Full Text] [Related]
27. Structural basis for germline antibody recognition of HIV-1 immunogens.
Scharf L; West AP; Sievers SA; Chen C; Jiang S; Gao H; Gray MD; McGuire AT; Scheid JF; Nussenzweig MC; Stamatatos L; Bjorkman PJ
Elife; 2016 Mar; 5():. PubMed ID: 26997349
[TBL] [Abstract][Full Text] [Related]
28. VRC34-Antibody Lineage Development Reveals How a Required Rare Mutation Shapes the Maturation of a Broad HIV-Neutralizing Lineage.
Shen CH; DeKosky BJ; Guo Y; Xu K; Gu Y; Kilam D; Ko SH; Kong R; Liu K; Louder MK; Ou L; Zhang B; Chao CW; Corcoran MM; Feng E; Huang J; Normandin E; O'Dell S; Ransier A; Rawi R; Sastry M; Schmidt SD; Wang S; Wang Y; Chuang GY; Doria-Rose NA; Lin B; Zhou T; Boritz EA; Connors M; Douek DC; Karlsson Hedestam GB; Sheng Z; Shapiro L; Mascola JR; Kwong PD
Cell Host Microbe; 2020 Apr; 27(4):531-543.e6. PubMed ID: 32130953
[TBL] [Abstract][Full Text] [Related]
29. Biased dA/dT somatic hypermutation as regulated by the heavy chain intronic iEmu enhancer and 3'Ealpha enhancers in human lymphoblastoid B cells.
Komori A; Xu Z; Wu X; Zan H; Casali P
Mol Immunol; 2006 Apr; 43(11):1817-26. PubMed ID: 16412510
[TBL] [Abstract][Full Text] [Related]
30. Immunoglobulin somatic hypermutation by APOBEC3/Rfv3 during retroviral infection.
Halemano K; Guo K; Heilman KJ; Barrett BS; Smith DS; Hasenkrug KJ; Santiago ML
Proc Natl Acad Sci U S A; 2014 May; 111(21):7759-64. PubMed ID: 24821801
[TBL] [Abstract][Full Text] [Related]
31. Recombinase-mediated cassette exchange as a novel method to study somatic hypermutation in Ramos cells.
Baughn LB; Kalis SL; MacCarthy T; Wei L; Fan M; Bergman A; Scharff MD
mBio; 2011; 2(5):. PubMed ID: 21990614
[TBL] [Abstract][Full Text] [Related]
32. Germline-targeting HIV-1 Env vaccination induces VRC01-class antibodies with rare insertions.
Caniels TG; Medina-Ramírez M; Zhang J; Sarkar A; Kumar S; LaBranche A; Derking R; Allen JD; Snitselaar JL; Capella-Pujol J; Sánchez IDM; Yasmeen A; Diaz M; Aldon Y; Bijl TPL; Venkatayogi S; Martin Beem JS; Newman A; Jiang C; Lee WH; Pater M; Burger JA; van Breemen MJ; de Taeye SW; Rantalainen K; LaBranche C; Saunders KO; Montefiori D; Ozorowski G; Ward AB; Crispin M; Moore JP; Klasse PJ; Haynes BF; Wilson IA; Wiehe K; Verkoczy L; Sanders RW
Cell Rep Med; 2023 Apr; 4(4):101003. PubMed ID: 37044090
[TBL] [Abstract][Full Text] [Related]
33. Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies.
Doria-Rose NA; Schramm CA; Gorman J; Moore PL; Bhiman JN; DeKosky BJ; Ernandes MJ; Georgiev IS; Kim HJ; Pancera M; Staupe RP; Altae-Tran HR; Bailer RT; Crooks ET; Cupo A; Druz A; Garrett NJ; Hoi KH; Kong R; Louder MK; Longo NS; McKee K; Nonyane M; O'Dell S; Roark RS; Rudicell RS; Schmidt SD; Sheward DJ; Soto C; Wibmer CK; Yang Y; Zhang Z; ; Mullikin JC; Binley JM; Sanders RW; Wilson IA; Moore JP; Ward AB; Georgiou G; Williamson C; Abdool Karim SS; Morris L; Kwong PD; Shapiro L; Mascola JR
Nature; 2014 May; 509(7498):55-62. PubMed ID: 24590074
[TBL] [Abstract][Full Text] [Related]
34. De novo identification of VRC01 class HIV-1-neutralizing antibodies by next-generation sequencing of B-cell transcripts.
Zhu J; Wu X; Zhang B; McKee K; O'Dell S; Soto C; Zhou T; Casazza JP; ; Mullikin JC; Kwong PD; Mascola JR; Shapiro L
Proc Natl Acad Sci U S A; 2013 Oct; 110(43):E4088-97. PubMed ID: 24106303
[TBL] [Abstract][Full Text] [Related]
35. Selection of immunoglobulin elbow region mutations impacts interdomain conformational flexibility in HIV-1 broadly neutralizing antibodies.
Henderson R; Watts BE; Ergin HN; Anasti K; Parks R; Xia SM; Trama A; Liao HX; Saunders KO; Bonsignori M; Wiehe K; Haynes BF; Alam SM
Nat Commun; 2019 Feb; 10(1):654. PubMed ID: 30737386
[TBL] [Abstract][Full Text] [Related]
36. The potential of the human immune system to develop broadly neutralizing HIV-1 antibodies: implications for vaccine development.
Zhang Y; Yuan T; Li J; Zhang Y; Xu J; Shao Y; Chen Z; Zhang MY
AIDS; 2013 Oct; 27(16):2529-39. PubMed ID: 24100711
[TBL] [Abstract][Full Text] [Related]
37. Outer domain of HIV-1 gp120: antigenic optimization, structural malleability, and crystal structure with antibody VRC-PG04.
Joyce MG; Kanekiyo M; Xu L; Biertümpfel C; Boyington JC; Moquin S; Shi W; Wu X; Yang Y; Yang ZY; Zhang B; Zheng A; Zhou T; Zhu J; Mascola JR; Kwong PD; Nabel GJ
J Virol; 2013 Feb; 87(4):2294-306. PubMed ID: 23236069
[TBL] [Abstract][Full Text] [Related]
38. Multidonor analysis reveals structural elements, genetic determinants, and maturation pathway for HIV-1 neutralization by VRC01-class antibodies.
Zhou T; Zhu J; Wu X; Moquin S; Zhang B; Acharya P; Georgiev IS; Altae-Tran HR; Chuang GY; Joyce MG; Kwon YD; Longo NS; Louder MK; Luongo T; McKee K; Schramm CA; Skinner J; Yang Y; Yang Z; Zhang Z; Zheng A; Bonsignori M; Haynes BF; Scheid JF; Nussenzweig MC; Simek M; Burton DR; Koff WC; ; Mullikin JC; Connors M; Shapiro L; Nabel GJ; Mascola JR; Kwong PD
Immunity; 2013 Aug; 39(2):245-58. PubMed ID: 23911655
[TBL] [Abstract][Full Text] [Related]
39. Sequencing HIV-neutralizing antibody exons and introns reveals detailed aspects of lineage maturation.
Johnson EL; Doria-Rose NA; Gorman J; Bhiman JN; Schramm CA; Vu AQ; Law WH; Zhang B; Bekker V; Abdool Karim SS; Ippolito GC; Morris L; Moore PL; Kwong PD; Mascola JR; Georgiou G
Nat Commun; 2018 Oct; 9(1):4136. PubMed ID: 30297708
[TBL] [Abstract][Full Text] [Related]
40. Conditional antibody expression to avoid central B cell deletion in humanized HIV-1 vaccine mouse models.
Tian M; McGovern K; Cheng HL; Waddicor P; Rieble L; Dao M; Chen Y; Kimble MT; Cantor E; Manfredonia N; Judson R; Chapdelaine-Williams A; Cain DW; Haynes BF; Alt FW
Proc Natl Acad Sci U S A; 2020 Apr; 117(14):7929-7940. PubMed ID: 32209668
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
